Opportunity

Simpler Grants.gov #PAR-25-182

NIH Grant for Development of Psychosocial Interventions for Mental Disorders (Clinical Trial Required)

Buyer

National Institutes of Health

Posted

November 26, 2024

Respond By

October 15, 2027

Identifier

PAR-25-182

NAICS

541720

This opportunity from the National Institutes of Health (NIH) seeks applications for research grants focused on developing and testing new psychosocial therapeutic and preventive interventions for mental disorders. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Mental Health (NIMH) - Scope of Work: - Development and pilot testing of novel psychosocial interventions for mental disorders - Emphasis on experimental therapeutics to translate behavioral, cognitive, affect, and neuropsychological research into practical interventions - Up to two years for pilot research (target engagement, intervention parameters) - Up to three years for replication and clinical outcome testing - Eligibility: - Open to nonprofits, small businesses, tribal organizations, government entities, and educational institutions - Products/Services Requested: - No specific OEMs or commercial products required - Focus is on research services and clinical trials, not procurement of hardware or software - Unique Requirements: - Clinical trial required (R61/R33 mechanism) - Must address mental disorders using psychosocial approaches - Must follow the experimental therapeutics framework - No OEMs or vendors are specified, as this is a research grant, not a product procurement.

Description

This funding opportunity from the National Institutes of Health supports the development and testing of novel psychosocial therapeutic and preventive interventions for mental disorders. It emphasizes the experimental therapeutics approach to speed translation of research in behavioral and neuropsychological science into interventions. The award provides up to two years for evaluation of target engagement and intervention parameters, and up to three years to replicate target engagement and test clinical outcomes. Eligible applicants include a wide range of organizations such as nonprofits, small businesses, tribal organizations, government entities, and educational institutions.

View original listing